Track the Generate Biomedicines, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). The latest transaction was filed on 6 March 2026 (Acquisition). Among the most active insiders: Nally Michael. The full history is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€237,972
4 ops.
Buy Volume
n/a
n/a
Sell Volume
52Σ signal
Buys €237,972n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Generate Biomedicines, Inc. is a biopharmaceutical company focused on developing protein-based therapeutics. It utilizes a protein design platform to create innovative therapies.